October 5, 2021
The Ministry of Health, Labor and Welfare (MHLW) on October 1 granted orphan drug designations for four APIs including Janssen Pharmaceutical’s nipocalimab. Nipocalimab was given the status for the expected indication of generalized myasthenia gravis. The three other APIs are:...read more